![Rodger Novak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodger Novak
Fondatore presso
Xap Therapeutics Ltd
Profilo
Rodger Novak ha fondato CRISPR Therapeutics AG e Nabriva Therapeutics GmbH. Attualmente, il Dr. Novak occupa la posizione di presidente di CRISPR Therapeutics AG. In passato ha occupato la posizione di Global Head-Anti Infectives Research & Development presso Sanofi Pharma SA, Chief Operating Officer per Nabriva Therapeutics GmbH, Head-Scientific & Medical Affairs presso Antibiotic Research Institute, Deputy Head-Antibiotic Research Institute presso Sandoz AG, Deputy Head-Antibiotic Research Institute presso Sandoz GmbH e Professor-Microbiology presso Vienna Biocenter. Rodger Novak ha ricevuto un dottorato dalla Philipps University di Marburg.
Posizioni attive di Rodger Novak
| Società | Posizione | Inizio |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/10/2020 |
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direttore/Membro del Consiglio | 01/01/2014 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Direttore/Membro del Consiglio | - |
Xap Therapeutics Ltd
 Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Fondatore | - |
Precedenti posizioni note di Rodger Novak
| Società | Posizione | Fine |
|---|---|---|
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2025 |
| CRISPR THERAPEUTICS AG | Amministratore Delegato | 01/12/2017 |
Sanofi AG | Corporate Officer/Principal | 01/11/2013 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 01/12/2005 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Fondatore | - |
Formazione di Rodger Novak
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
32
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Antibiotic Research Institute
 Antibiotic Research Institute Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and biotechnological drugs | Health Technology |
Sanofi AG | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vienna Biocenter
 Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Operates biology research center | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Health Technology |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
